Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.

Fuchs SC, Poli-de-Figueiredo CE, Figueiredo Neto JA, Scala LC, Whelton PK, Mosele F, de Mello RB, Vilela-Martin JF, Moreira LB, Chaves H, Mota Gomes M, de Sousa MR, Silva RP, Castro I, Cesarino EJ, Jardim PC, Alves JG, Steffens AA, Brandão AA, Consolim-Colombo FM, de Alencastro PR, Neto AA, Nóbrega AC, Franco RS, Sobral Filho DC, Bordignon A, Nobre F, Schlatter R, Gus M, Fuchs FC, Berwanger O, Fuchs FD.

J Am Heart Assoc. 2016 Dec 13;5(12). pii: e004248.

2.

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H.

Hypertension. 2015 Dec;66(6):1123-9. doi: 10.1161/HYPERTENSIONAHA.115.06236. Epub 2015 Oct 12.

3.

Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis.

Georgianos PI, Agarwal R.

PLoS One. 2015 Sep 10;10(9):e0135457. doi: 10.1371/journal.pone.0135457. eCollection 2015.

4.

Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic.

Ching S, Chia Y, Wan Azman W.

Malays Fam Physician. 2012 Aug 31;7(2-3):2-9. eCollection 2012.

5.

Dietary Intake Ratios of Calcium-to-Phosphorus and Sodium-to-Potassium Are Associated with Serum Lipid Levels in Healthy Korean Adults.

Bu SY, Kang MH, Kim EJ, Choi MK.

Prev Nutr Food Sci. 2012 Jun;17(2):93-100. doi: 10.3746/pnf.2012.17.2.093.

6.

Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment.

Garg B, Yadav N, Vardhan H, De AK.

J Clin Diagn Res. 2013 Aug;7(8):1599-603. doi: 10.7860/JCDR/2013/6227.3235. Epub 2013 Aug 1.

7.

Effect of telmisartan on the regression of the left ventricular hypertrophy in the patients of essential hypertension.

Misra KH, Das MC, Ramani YR.

J Clin Diagn Res. 2013 Jul;7(7):1352-5. doi: 10.7860/JCDR/2013/5416.3127. Epub 2013 Jul 1.

8.

Change in cardiac geometry and function in CKD children during strict BP control: a randomized study.

Matteucci MC, Chinali M, Rinelli G, Wühl E, Zurowska A, Charbit M, Pongiglione G, Schaefer F; ESCAPE Trial Group.

Clin J Am Soc Nephrol. 2013 Feb;8(2):203-10. doi: 10.2215/CJN.08420811. Epub 2012 Nov 2.

11.

Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.

Katholi RE, Couri DM.

Int J Hypertens. 2011;2011:495349. doi: 10.4061/2011/495349. Epub 2011 Jun 30.

12.

Stopping the cardiovascular disease continuum: Focus on prevention.

Chrysant SG.

World J Cardiol. 2010 Mar 26;2(3):43-9. doi: 10.4330/wjc.v2.i3.43.

13.

Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes.

Loimaala A, Groundstroem K, Rinne M, Nenonen A, Huhtala H, Vuori I.

Cardiovasc Ultrasound. 2007 Sep 26;5:32.

15.

Moexipril and left ventricular hypertrophy.

Chrysant GS, Nguyen PK.

Vasc Health Risk Manag. 2007;3(1):23-30. Review.

17.
18.

1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, Floras JS, Haynes RB, Honos G, Leenen FH, Leiter LA, Logan AG, Myers MG, Spence JD, Zarnke KB.

CMAJ. 1999;161 Suppl 12:S1-17.

19.
20.

Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Sheridan DJ, Kingsbury MP, Flores NA.

Br J Clin Pharmacol. 1999 Feb;47(2):125-30. Review. No abstract available.

Supplemental Content

Support Center